ADULT T ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for ADULT T ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ADULT T ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ADULT T ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Intensive combo therapy tested in High-Risk leukemia
Disease control OngoingThis study tested a multi-part treatment for adults with a specific, aggressive type of acute lymphoblastic leukemia (ALL). The goal was to see if combining intensive chemotherapy, a targeted drug called dasatinib, and for some patients, a stem cell transplant from a donor, could…
Matched conditions: ADULT T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
Major trial seeks better treatment for aggressive childhood cancers
Disease control OngoingThis large, late-stage trial is testing whether adding a drug called bortezomib to standard chemotherapy works better for treating newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LLy). The study involves 847 children and young adul…
Matched conditions: ADULT T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC